Preprint · CC-BY
via OpenAlex
Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes
Juanhong Liu, Yuanlong Ge, Shu Wu, Delin Ma, Weijie Xu, Ye Zhang, Yan Yang
Aging · 2019 · ▲ 28 citations
Abstract
Telomere(definition) length and telomere shortening rate (TSR) are accepted indicators of aging in cross-sectional population studies. This study aimed to investigate the potential influence of common antidiabetic agents on telomere length and TSR in patients with type 2 diabetes mellitus (T2DM). Leukocyte telomere length was measured through terminal restriction fragment analysis, and TSR was calculated in 388 T2DM patients. Depending on whether or not they received antidiabetic medication, patients were first divided into a treatment group and a nontreatment group. Treated patients were further subdivided into an acarbose-free group (patients taking antidiabetic agents without acarbose) and an acarbose group (patients using acarbose for more than 3 months). Results showed that untreated patients had higher TSRs than patients on antidiabetic drugs. Interestingly, patients in the acarbose group had significantly higher TSRs than patients in the acarbose-free group. Compared to the nontreatment group, the acarbose group showed better glycemic control of HbA1c, but the TSR was also higher. Our results suggest that antidiabetic treatments without acarbose can slow aging. By contrast, acarbose may accelerate biological aging in patients with T2DM, independently of glycemic control.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.101781
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Liu, J., Ge, Y., Wu, S., Ma, D., Xu, W., Zhang, Y., & Yang, Y. (2019). Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. <em>Aging</em>. https://doi.org/10.18632/aging.101781
Vancouver
Liu J, Ge Y, Wu S, Ma D, Xu W, Zhang Y, et al. Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. Aging. 2019. doi:10.18632/aging.101781.
BibTeX
@unpublished{juanhong2019Associ,
title = {Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes},
author = {Juanhong Liu and Yuanlong Ge and Shu Wu and Delin Ma and Weijie Xu and Ye Zhang and Yan Yang},
journal = {Aging},
year = {2019},
doi = {10.18632/aging.101781},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gerontology 2020
Citation only
The Association between Antidiabetic Agents and Leukocyte Telomere Length in the Novel Classification of Type 2 Diabetes Mellitus
Fetal and Pediatric Pathology 2019
Citation only
Telomere Length Inheritance and Shortening in Trisomy 21
Medical Science Monitor 2017
Open access · CC-BY
Association Between Oxidative Stress and Peripheral Leukocyte Telomere Length in Patients with Premature Coronary Artery Disease
European Respiratory Journal 2016
Open access · OA
Accelerated telomere attrition in children and teenagers with α1-antitrypsin deficiency
Future Microbiology 2021
Citation only
Insights into the Gut Microbiome and Its Functional Pathways in Asthma Patients Through High-Throughput Sequencing
Transplantation Direct 2016
Open access · CC-BY